INTRODUCTION
The definition of the word 'minor' according to the Concise Oxford Dictionary 1 is: 'comparatively unimportant (for example: minor poet) or in case of Operation: presenting no danger to patient's Iife'. Consequently, in our discipline, the 'majors' (histocompatibility antigens) must account for the greatest obstacle in human organ exchange; a barrier which in all probability was already playing a role in ca 300 AD when two sibling doctors, Saint Cosmas and Saint Damian, carried out a total leg replacement. Nowadays even with the use of a new potent immunosuppressive drug, Cyclosporine A, the renal transplant recipient still benefits from a well matched organ donor. 2 The fact that minor histocompatibility (minor H) antigens are 'allied' to the major Η antigens probably raises one's interest in them. This is based on the assumption that major Η molecules serve as salvers for foreign antigens, such as foreign minor Η antigens, thus triggering an immunological Τ cell response. 3 This chapter will deal with the recognition of human minor Η antigens, the genetics of these antigens at the population level as well as in families, and finally their possible impact on the outcome of bone marrow transplantation will be discussed. This review does not pretend to cover all Information regarding the influence of non-MHC antigens on the outcome of organ transplantation, but rather reflects a summary of our own cellular immunological in vitro studies in relation to bone marrow transplantation in man in particular.
INTRODUCTION TO AND RATIONALE OF THE STUDY
It is now 49 years since the first human bone marrow transplantation was carried out. 4 In the 1950s, the first series of clinical applications of bone marrow grafting was reported. 5 ' 6 Thanks to Mortimer Bortin, a compendium on the results of the W Goulmy first 203 human bone marrow tiansplants performed as therapeutical treatment ol scverc dplastic anaemia, leukaemia and immune deiitiency disease became available in 1970 7 Although, the graft versus-host (GvH) reaction histoncally dates from early this Century, 8 the high numbei of deaths in the latter report, was not attnbutable to GvH disease Notwithstanding Ceppellmi's Statement in 1967 'there IS httle doubt however that the motivation of Nature in selecting for a genetic polymorphism of this complexity, was not an α priori hostibihty against transplantaüon surgeons', 9 lt is clear that in an artificial Situation, such as organ transplantation, the major Η antigens function as a major transplantation barner and thus play an important role in the survival of transplants and patients Consequently, improved success in bone marrow transplantation was reported when matching for the HLA antigens was taken into aecount 10 Between 1975 and the present day, the long-term results of allogeneic bone marrow transplantation have greatly improved due to the use of HLA matched sibhngs as marrow donors, advanced pretransplant chemoradiotherapy, the use of potent immunosuppressive drugs as prophylaxis, better antibiotics and Isolation procedures Despite the promising advances, the Overall results achieved so far are still not completely satisfactory Graft versus host Disease (GvHD) affects (despite the selection of HLA identical sibhngs as bone marrow donors) approximately 20-70 percent of the patients depending on their age " 12 The aetiology of GvHD presumes that immunocompetent donor Τ cells are reaetmg against the host tissues Thus, when endeavounng to prevent GvHD development, donation of marrow deplcted from mature Τ cells has become a frequently used regimen Unfortunatcly, this treatment also has lts drawbacks Graft failure or rejeUion as wtll as recurrence of the original disease have been leported as major eomphcations following Τ lymphocyte depleted bone marrov transplant n 14 The severe, and in some cases fatal comphcations following these marrow transplants justify the search for at least one of the obstacles to successful bone marrow transplantation In human transplantation, donors and recipients are routinely screened tor Identification of the major Η System, therefore GvHD and rcjection may be caus^d by the dispanty of the produets of the so called 'minor' Η Systems, ι e histocompatibihty antigens other than those coded for by the MHC Skm grafting expenments in the mouse demonstrated the presence of a large number of histocompatibihty antigens uoded for by multiple loci scattered all over the genome 1 hey show distinguishable patterns in ehciting allogeneic reaction, skin grafting over a multiple minor Η barnei demonstrates a graft rejection time eomparable to those that differ only at Η 2
1S l7
Prior to the detection of the possible involvement of human minor Η antigtns in the development of GvHD aftei HLA genotypically identical bone manow grafting, 18 convincing results weie reported in the mouse demonstrating that, using congemc stiains of mice, incompatibility for non Η 2 antigens alone can lead to a high rate of GvH mortahty u 2I Moreover, the Τ cells causing lethal GvHD atross minor Η barners appeai to be Η 2 iestucted Thus Γ cells re^ponsible for induction of GvHD to minor Η antigens do not respond in vivo to the samc minor Η antigens picsenled on Η 2 different cells 22n
CELLULAR IMMUNOLOGICAL IN VITRO STUDIES OF HUMAN BONE MARROW TRANSPLANTATION
Figure 3-1 functions as a guidehne according to which I will treat the major effects resulüng from bone barrow transplantation, lllustrated with, as far as possible, the results of our in vitro studies First, the studies deahng with graft failure/rejection will be discussed Second, the complication of GvHD will be examined, exemplified with in vitto studies reflecting the graft-versus-host attack Finally, I would hke to touch bnefly on the possible 'graft-versus-leukaemia' (GvL) effect On the other hand, a ehnical so ealled 'no takc' obseivation aftcr bone mairow gralling, donaled by a male sibling donor to his HL Α gcnotypieally identieal sisttr, was reported to us Tortunately, this dinieal event led us not only to the first dcmonstration in man of thc partiupation of the Hl Α molctulcs in the inteiaction of Τ teils with foreign antigen, but also brought us into the mysteiious world of minor transplantation antigens of whith the male spcufic antigen Η Υ is the lar easiest and also the most extcnsively minor Η antigen studied
1S1(
I he Inst repoit of Η Υ as a transplantation antigen is an untitled tommumcation by L-ithwald and Silmser in 1955 These authors observed that within (wo inbred stiams ol nuce, most ol the male to iemale skin gratts were rejeeted, wheieas tiansplants made in other sex eombinations nearly always sucteeded 27 The tcrm Η Υ antigen was mtrodutcd by Bilhngham and Silvers 28 beeause the male spetilic antigen can funetion as a classical transplantadon antigen responsible (oi homogial! icjection An important Step in the retogmtion of the H-Y antigen in vitro, using Η Υ immune spieen cells obtamed liom in vivo immuni/cd Iemale mite, was repoitcd by Goidon et al '' In vitio cell mediatcd cytotoxie lesponses to the male spetilie antigen Η Υ wert found to be Η 2 lestneted, ι e CTI s recogni/e loieign antigens, such as Η Υ, only when they aie presented to the C Γ1 s on cells which shaic some homology ol the Η 2 icgion as expressed on the ellettor C Π s Snnilarly, the ictognition ol othei minor Η antigtns by C TI s is also MH( lestnetcd '"
Results in View of Climtal Lase\
Returmng to oui clmical easc, in vitio analysis ol the posttransplant penpheial blood lymphocytes (PB1 s) of the Iemale paticnt (Hl Λ phenolype Hl Α Λ2, Λ2, B44, B60, Cwl, Cvv5, DR4, DRw6) showed unambiguously stiong CTI icsponses speeilie foi male HL Α A2 positive target teils ls 1( Whether the Η Υ spceifie Cl 1 s attually mediated thc allogiall rejcttion, we do not know It must bt icmaiked, howtver, that most probably the Iemale palicnt, who was sulleiing liom scveie aplaslic anacmia, had becn scnsiti/ed to the Η Υ antigen ρποι to (lanspianfadon (htough multiple (niainly male) blood tianslusions and picgnancics This assumption is based on out substqutnt obseivations As shown in Fable 3 1, PB1 s denved liom loui additional tases showtd, altei /// vitio icstmuilalion with Hl Α identital male ttlls txattly the same phenomenon, nanicly Hl Λ rcstrietecl (AI, A2 and/or B7) anti H Υ tytotoxit l teil activity In one paticnt (ι t ( ase 5, lable 3 I), HK Η Υ specific Hl Α Β7 reslnücd tytotoxitity was detetttd shortly alter an atutel> itjtttcd kidney donated by an HI Λ identical male sibling (unpublishtd oDscivation) In tncumsidiices similai lo ours, othet investigators also destubed the picsence ol Hl Λ itsltitttd H Υ dnected tytotoxitily " Ο MHC restnctmg antigens
Aplastic anaemia
Althoügh in our first ease we formally could not prove that the Η Υ specihc CTI s actually mediated the rejection ot the male allograft, vcry retently we have been Lonfronted with a case with a fatal outcome, in which anti Η Υ CTLs weie most piobably mainy responsible for graft rejection It concerned a multitransfused female patient suffenng from myelodysplasia alter treatment for Hodgkin's disease In vitro analysis demonstrated the presence of HLA-A1 restntted anti Η Υ CTI s (1 able 3 1, ( ase 4) Since the father appeared to be the only HLA compatible related donor, he was the obvious choice (despite, unfortunately, the presence of patient's prettansplant inti Η Υ CTLs) Notwithstanding intensive pretiansplant immunosuppicssive tiuitment and the donation of Τ cell depleted marrow there was no lecovery ol the patient's bone manow haematopoietic tunction (Voogt et al , ms in preparation) With hindsight, the choice of an unrelated HLA identical (or comnatible) (emale bone marrow donor might eventually have led to a less diamatic result The tonsideration of choosing in favour of an unulated -or even a partially HLA nusmalched donoi-will be treated in more detaii elsewhere in this chaptei Inlerestingly, it IS not only very recent reports," M but reports sin< e 1977, 1S which have pointed towards sex mis-match as oneof thensk fattois assouated with GvHD oi icjection According to the most recent data collected worldwide and evaluated b> the Advisory Committee of the Inteirational Bone Manow Registiy " 14 male lo lemale, and female-to male transplants have a high chance of rejection respectivcly d\HDin acute myelogenous leukaetma(AML), acute lymphoblastic leukaemia (AI L), Juonic myelogenous leukaemia (CML) and severe aplastic anaemia (SAA) Wiih Special legaid to marrow treatment in the latter disease, I think it might be helplul io a certain extent to be awaic ol the apparcntly lairly high incidence in vilio ol CTI s ihicetcd against the male specific antigen H-Y Λ rcpoit on the piesence ol anti Η Υ lAiotoxiuty in an untiansiused 11 yeai old female patient with SAA, luither siiengthens this point "' 1 hc clinical relevance of the Η Υ alloantigcn on the lesults ol human kidney allogiaft Mansplantation has also been determined Α retrospective study showed a significant dilkience between HLAA2 females receiving HI Α Α2 male kidneys and non Hl Α A2 females receiving non HLA A2 male kidneys, 2 ycais aftei tiansplantation Male allografts from HLA A2 positive donors in HLA-A2 positive females survived for a significantly shorter time than non-A2 male kidneys in non-A2 female retipients "
Perspectives
To elaborate on the assumption that minor Η antigens such as H-Y do indeed play a role in the success of graft exchange between HLA identical siblings in general and in Τ cell depleted marrow in particular, we investigated the expression of this minor Η antigen on haematopoietic progenitor cells (HPC). For this purpose, an in vitro cellular cytotoxicity assay with bone marrow cells as target cells has been developed 38 In bnef, in vitro sensitized HLA-A2 specific CTLs were incubated with bone marrow mononuclear cells derived from, for example, HLA-A2 positive or HLA-A2 negative donors Complete Inhibition of growth was observed in the myeloid, erythroid and multipotential HPC from the HLA-A2 positive individual, 38 whereas normal outgrowth of HPC cultures was observed in the bone marrow cells from HLA-A2 negative donors Naturally, the next step was to investigate whether or not the H-Y antigen IS expressed on human HPC The results of these expenments show that indeed the H-Y antigen is expressed on HPC 39 These observations support the notion that the minor Η antigen H-Y is by and large hkely to play a role in the failure of (stable) marrow engraftment, particularly in the graft failure of Case 4 as discussed in the previous section
Little is known about the nature and exact function of the histocompatibihty antigen H-Y Recent examination of sex-reversed humans by combined analyses of different sets of Y-DNA probes and H-Y specific CTLs revealed that the gene for Η Υ maps to the long arm or centromenc region of the human Υ chromosome 40 Hopefully, we will reach the State in which we can study which peptide(s) (obtained either by cleavage of the H-Y gene product or chemically snythesized) forms the lmmunogenic complex with the MHC class I (HLA-Al, -A2 or -B7) molecules as recogni/ed by the CTLs Thereupon, one could think of making antibodies against such peptide(s) which could block the specific cytotoxic activity as well ds neutrahze the intact H-Y protein so that the individual is protected from unwanted H-Y d'retted cytotoxicity
The interaction of the Η Υ antigemc peptide(s) with lts 'salver' is also interesting In the light of our fmdings the H-Y antigen preferentially binds to the HLA-A2 molecule Therefore analysis of the epitopes on the HLA-A2 molecule required foi cellular recogmtion of the H-Y antigen has been tarned out These studics led to the observations that alloimmune HLA-A2 specific CTLs Absence of recogmtion was only observed when male donor M7 was tested as target cells 47 The sole difference between M7 and AM is an additional amino acid change at position 9 in AM which is absent in M7 Despite the hmited Information which is available so far, these results further strengthen the postulated interaction of position 9 in the a t domain of HLA-A2 molecule with antigen The amino acid change at position 9 from Phe to Tyr is identical between Cla and AM but is the difference between AM and M7 These data suggest that tyrosine is a candiddte for the binding of H-Y into the groove of the top of the HLA-A2 molecule
The 'Other' Minor Histocompatibility Antigens
l'olymorphic Blood Genetic Markers
Before discussing the method of detection, identif lcation and genetics of our minor HA antigenic System and lts possible influence on the development of GvHD, the involvement of other putative 'minor' non-HLA histocompatibility antigens in GvHD should be mentioned Sparkes et al 48 reporteü on a significant correlation between compatibihty for the blood group System MNSs betwen donor and recipient and CivHD, incompatibility for this System may result in GvHD Similaily, De Gast et dl A9 studied the association between 22 polymorphic blood genetic markers and dvHD Three (ι e rhesus, MNSs bloodgroup and acid phosphatase) of the 22 markers appeared to be involved in GvHD Mismatching lor all three markers showed an additive effect and significant correlation with GvHD
The Minor Histocompatibility Antigens 'HA ', the origin of HA-1
Again, a chmcal case opened our eyes to the first demonstration in man of possible involvement of minor Η antigens (other than H-Y) in the development of GvHD 1 he sccond part of the section on cellular lmmunological in vitro studies of human hone mairow transplantation will deal with GvHD (see Fig 3- 1) The occurrence of ι severe GvHD in a bone marrow-transplanted male AML patient piompted us to nncstigate the in vitro cytotoxic activity of the patient's posttiansplantation hmphocytes The patient had becn transplanted with bone manow from an HL Α ldentital lemale sibhng donor His chnital retovery, however, was eomphcated by severe ehronie GvHD The initial expenment demonstrated that the posttransplant lymphocytes had strong eytotoxic activity against the patient's own /vetransplant lymphocytes but not against the lymphocytes of his HLA identical donoi l8 This obseivation in ltself Supports the notion that whatever the target determinant recogmzed by the latter CTLs, the HLA genotypically identical donor and recipient differed for lt From additional analysis of the patient's posttransplant CTL activities, lt became appaient that the antigen (which we designated minor Η antigen HA 1) was not only piesent on the patient's own pretransplant cells, but could also be detected on lymphocytes from two out of three haplo identical siblings as well as on the lymphocytes of the parents, and also on lymphocytes from a laige number of unrelated healthy individuals The antigen HA 1 could be recognized by the patient's positransplant CTL only if one of the patient's HLA class 1 antigens was present on the target cells 5() Consequently, HA 1 IS recognized in an MHC restneted fashion, an event comparable to the recogmtion of Η Υ and similar to that desenbed in the mouse (see ρ 30)
Since strong anti minor Η antigen cytotoxic activity was observed in a patient suffenng from severe GvHD after HLA identical bone marrow transplantation, it was reasonable to assume that there might exist a correlation between both in vivo and in vitro observations Based on this concordance, we feit it was justified to contmue our search for non HLA antigens and their possible role on the outcome of bone marrow transplantation For this purpose we used the simple, yet labonous, method as outhned in the following section
Methodology
The basic idea of generating anti host CTLs with specific cytotoxic activity for non HLA antigens is based on the assumption that posttransplant (i e donor) cells when sensitized against the patient's own pretransplanl cells, are directed against host specific target struetures, such as minor Η antigens, which are absent Irom the donoi cells 7 his supposition is plausible since our sludies have been carned out with nutenal obtaintd from HI Α genotypically identical bone marrow donor and lecipient combinations
The protoeol, which we commonly use, enables not only the genoration of anti host CTLs posttransplantation of bone marrow, but also the estabhshment and expansion of minor Η antigen specific CTL hnes The success of this was due to a crucial, in fact logical, cultunng pohey and an imphcit confidence in sueeeeding Ptupheral blood lymphocytes (PBLs) taken from the patients shortly after bone marrow transplantation look disastrous So, the tnck is to prime the 6 day old lesponder/stimulator ccll cultuies with specific stsmulator cells and highly punfied intcrleukin 2 (HP 11 2) for 3-4 days (see I ig 3 2) This restimulation is just suflicient lor the few surviving cells lo recover and to Start prohfeiating The HP 1L 2 is prcferable to reeombinant IL 2, because it contains small amounts of extra possible growth factors fherealter, the effector cells are regularly fed with, most prcferably, the original stimulator cells (or if not available, lymphocytes from Hl Α ldtntical unrelated healthy individuals) and Τ cell giowth factor(rCGI) Since each individual 13d. 18d. 25d 32d.
CML assay and storage of effector cells
Figuse 3-2. Flow chart for generation of anti-host CTLs CML = cell mediated lympholysis HP IL-2 (highly punfied inter leukin-2) and TCGF (T cell growth factor) are both commercially available from Biotest HP IL-2 IS used in the first restimulation, thereafter TCGF is added for growth promotion Recommended cell numbers at day 0 mimmum of 2 10 6 responder cells and 2 10 6 stimulator teils in 2 ml of culture medium
Lcll-hne has Us own growth kinetics, the optimal effector cell yield and cytolytic activities can only be achieved by paying attention to each effector cell combination individually Onte reasonable growth is obtained (in general between 12 and 20 days of culture), the effector cells are first tested for specific ~ytotoxic activity ι e patient's prttransplant lymphocytes Subsequently, further expansion of the CTLs is provided b> the alternate addition of feeder cells and TCGF Specific cytotoxic Τ cell activity is measured by the use of the cell-mediated lympholysis (CML) assay pieviously uYscnbed in detail 5I
inti-host Cytotoxic Τ Cell Activities
Next, we aimed at both coniirmation and extension of oui first results regarding the possible impact of polymorphic genetic Systems other than HLA on the development ol GvHD in man For this purpose, we investigated posttransplant lymphocytes from a senes (Λ = 28) of recipients of HLA identical bone marrow grafts for the presence o! anti-host CTL activity Posttransplant lymphocytes from 17 out of 21 patients sulfenng from GvHD demonstrated CTL activity (Table 3 -2), which was directed mamst patients' own pretransplant lymphocytes Host directed CTL could so teil be demonstrated in all (except one) patients suffenng from chiornc GvHD I uilhermore, in five out ot eight patients with acute GvHD, anti host CTL activity was also observed One of the lattei CTL populations (designated as 'anti HA 3' < IL s) has been analysed extensively and will be discussed in the following sections I he remaining foui anti host CFL populations generated with posttransplant PBLs I1 om patients with acute GvHD and those geneiated in the two patients without GvHD u <-uirrcntly under investigation We do not know yet whether the cytotoxic eftector 11 populations and the target struetures they are directed at die diffeient in the acute patitnts or those suffenng from chronic GvHD At the moment we cannot also piovidi Information on the specific reaetivity of the populations observed in patients withou any clinical signs of GvHD, except for one donor/recipient combination in th( 'no GvHD' group where an HA-3 incompatibility was observed (see subsequen settions where the inverse torrelation of the HA 3 antigenic determinant with the oecurrence of GvHD will be discussed)
At present, we are also attempting to gain insight into the kmetics ol the in vitic anti host responses, betause to date our search lor anti host CT1 activity has beer hmited to one posttransplant (±40 days) bleeding date The appearance and eventua dccline of both prohferative and cytotoxic <mü host Τ cell activities have beer systematically analysed The results so far show that host-dnected Τ cells can bt detected from 25 days to 25 months after bone manow transplantation, the lattei long lasting anti host CTLs was observed in a patient suffenng from chconic GvHD (van Eis et al , manusenpt in preparation)
The results of the anti-host CTl activities posüransplantation oi bone mai row can bc summari7ed as follows lirst, posttiansplant anti host CTl attivity can be gencrated in patients suffenng from chronic GvHD As far as analysed, these activities an extiemely high and long lasting Second, m five out ofeight patients with acute GvHD anti host cytotoxic responses were lound, the latter patterns however are rather variable in appearance and activity Third, anti host Τ cell activities can be present in some patients without GvHD and thus do not umquely appear in patients with GvHD suggesting that anti host CTL are not the sole mediators of GvHD These prclimmaiy Undings in man are in hne with results reported in mice S2 Finally, that host directed Γ cell activities in patients without any clinical signs of GvHD and also in patients suffenng from acute GvHD only are observed, louches upon an interesting lssue, numely η ma> lead us to the identil ication of the populations responsiblc for ehciting the graft versus lcukaemia (Gvl ) reaction This will be discussed later
Genetics oj the HA Antigenic System
Similar to the initial anti host specific CTLs ΉΑ Γ (as discussed previously), wc next endeavoured to uncover the specificity oi the ta\gel structuies lecogm/ed by some ol the anti host CTLs (see Fable 3 2) 1t IS worth noting that such CTLs can be denved from uther male or female patients suffenng from different haematologic In Order to gain msight into the genetics of the HA antigenic System, vve investigated the relatives of the bone marrow donor/recipient combinations (between whom wc generated the ^everal HA specific CTLs, see Table 3 -2 and 3-3), with HA-1 to HA-5 specifit cytotoxic Τ cell reagents The pedigree of one of these five famihes is given in Fig 3-4 The reactivity patterns in these patients' famihes (and also in other randomly chosen famihes, Goulmy et al , ms in preparation) showed clearly segregation of the HA antigens They also demonstrate that HLA identical sibhngs tan diffet lor the HA antigens I or example in the family of patient HA-4 (Fig 3-4) , healthy sibhngs 09 typed differently from her HLA identical sibhngs 04, 06 and 10 Thest latter sibhngs typed identically for HA-1,2,4 and 5 among each other, likewise sibhngs 05 and 11 O( interest is that the HA-2 antigenic determinant which is piesent on the mdternal cells (00) is apparently lost in the third generation (i e 82 ,  Fig 3 4) } inally, as exemphfied in Fig 3-4 and observed in all bul one (i e HA-3) donor/recipient combinations which led to the creation of the HA specific CFLs, the donors and reupients differ for more than one minor HA antigen Consequently, CFls geneidtcd fiom posttransplant lymphocytes fiom patient 4 leading to the cytotoxic Τ cell population designated as HA-4 specific CTI clones (Fig 3 4) must also be present directed against HA-1 and HA-5 The panel analysis (Table 3- with the latter notion, ι e the HA-1 specificity IS present in the HA-4 effector cell bulk population Evaluating the analyses in families, in the population, and the cold target Inhibition studies carned out so far, the propositions for the HA antigenic System are as follows the HA 1 antigenic specificity is included in the HA-2 'specific' CTLs but is different from the HA-2 antigenic determinant and, both are different from HA-4 and HA-5, the latter two are most probably ahke Α pronouncement upon the possible location of the genes coding for the HA-1,2,4 and 5 productsis, at this point of investigation, not justified Current exammation of a large number of families will hopefully enable us to answer the question of whether or not they are linked to HLA
Results in Relation to the Clinical Situation
Based on the observation that host-directed CTLs specific for minor Η antigens tan be generated posttransplantation of bone marrow in patients suffenng from GvHD, a retrospective analysis has been performed to study the relationship between HA incompatibilities and the occurrence of GvHD in a senes (n = 87) of HLA identical donor/recipient combinations The five well defined minor Η antigen specific CTLs (HA 1 to HA 5) were used as cellular typing reagents Table 3 -5 demonstrates that incompatibilities for HA-1,2,4 and/or 5 between bone marrow donor and recipient oceurred preferentially in the group of patients suffenng from GvHD In some (n = 4) HLA A2 positive pairs, HA-1,2,4 oi 5 was absent in the recipient, but present in Ihe donor These 'reverse' incompatibilities can play a role in GvHD, and will always influence possible graft rejection Concentiating on the HLA-Al restncted mmor Η antigen HA-3, our studies to date do not imply a correlation of the HA-3 antigen with the occurrence of GvHD Despite the fact that the HA-3 specific CTLs were onginally generated in a paticnt sulfenng from acute GvHD, the retrospective typing analysis in HLA AI positive pairs (Table 3 5 with their donor for HA 3, were mismatched in the 'reverse' direction (1 e HA 3 present in the donor, but absent in the recipient) The number of bone marrow donor/recipient pairs investigated to date exceeds the number presented earlier 51 It must be remarked that this analysis showed a significant associdtion between the HA 1,2,4 and 5 incompatibilities and the occurrence of GvHD Now that we have investigated almost twice the number of donor/recipient pairs, the latter correlation hardly reaehes a significant level (Table 3 5 , p = 0 04) One of the possible explanations for these observations IS that in at least four of the ten HA 1,2,4 and five identical donor/recipient combinations in the group of paüents suffenng from chromc GvHD, wegenerated anti host CTL populations which could ιecognize minor Η antigens other than HA 1,2,4 or 5 Moreover, assuming that HA 4 is indeed identical to HA 5 and that HA 3 incompatibility does not play a role in the development of GvHD, then we must reahze that we used only three minor Η antigen typing reagents which obviously is not sufficient for a large number of donor/recipient combinations 
l'erspectives
At present our studies are extended to a posttransplant follow up time ot 2 years As mentioned earlier, the cytotoxit and prohferative Variation of activity and the phenotypic markers of the anti host Τ cell hnes of a senes of patients are presently under study (van Eis et al , manuscnpt in preparation) Hopefully, thcse studies will provide us with Information about the average number and the individual immuno gemcity of the minor Η antigens, so that the most immunodorninant HAs can be mapped actordmg to their impact in GvHD or rejectson
The HA specific CTI populations and CTL clones can be expandcd on a large scalt, fro7en and, when preferred, used directly after thawing as typing reagents providing in pnnciple, the clinician with results within 4 hours Prosoective donor tvping for the most common and 'strongest' minor Η antigens may be helplul in avoiding at least one of the obstacles to successful bone marrow transplantation This might be especially true in such cases as when patients lack an HLA identical sibhng, wheie more than one potential unrelated donor is available In this connection, it would be helpful lf collaborative studies could be undertaken aimed at exchanging and comparing Information and matenal between interested parties Recognition of human minor Η antigens has been reported by several investigators Elkins et dl S4 and Zier et al " desenbed tlit recognition of a human minot alloantigen by lymphocytes denved from a multitransfused aplastic anaemia patient Ihcy showed that the lymphocytes irom this in vivo sensitized patient, restirnulated /// vitro using HLA mismatched stimulatoi cells, rccogmzed a non HLA antigen in an MHC restneted fashion lesting of the paticnt's lymphocytes against a panel o( lymphocytes from unrelated individuals, and in famihes, indicated that the class I molecule B7 was involved in the recognition of the minor Η antigen Tekolf and Shaw 5f demonstrated that in vivo pnming by pregnancy seemed to be sufficient to generate cytotoxic Τ cells against a human minor Η antigen PBLs from a normal femalc, after secondary in vitro Stimulation with cells from an HLA Α, Β , C and D matched donor, showed strong cytotoxicity against a minor Η antigen in an HLA restncted fashion The restncting molecule was again HLA B7 Also, after irreversible rcjection of an HLA identical sibhng kidney allograft, CTLs directed against minor Η antigens could be demonstiated in vitro 57 An elegant study was performed by Sondel et al 58 who attempted to generate effector cells specific for leukaemic blasts Despite the fact that indeed the effector cells recogmzed the leukaemic target cells the non leukaemic lymphocytes from both parents of the patient were also lysed, suggesting the lecognition of a minor Η antigen by these CTLs However, a different approach for generating anti minor Η antigen specific lesponses has been forwarded by Tekolf and Shaw 59 Their data indicated that minor Η antigen speufic CTLs can be generated in vitro, without pnor in vivo priming, by usmg a hmiting dilution System through which suppressor cells are diluted out of the culture System Finally, Irle et al 60 descnbed anti minor Η antigen responses posttransplantation of bone marrow, in essence this was an expenmental set up comparable to ours The posttransplant CTL clones were directed against a rmnor Η antigen whose recognition was HLA B7 restncted It IS of note that HLA B7, along with HLA A2, appears to function well as a restncting antigen for minor Η antigens Uns can be concluded from these studies and also from the preference of the Η Υ uitigen tor HLA A2 and B7 as noted earher Moreover, among our new senes of patients who are presently under investigation, HLA B7 in addition to A2 turned out to be their favounte restncting molecules
The future use of more unielated marrow donors makes it obhgatory to know how to distinguish between pernicious and harmless minor Η and major Η antigens With Kgard to the former, one could Image that for example by mismatching foi HLA A2 ind selecting the serologically tross reactive HLA A28 antigen, no generation ol HI Α A2 restncted anti minor Η antigen responses would be mduced Moreovei, with tc^ard to the major histocompatibility anhgens, Identification ot the functionally important molecules could lead practitally to more potential donors and would hopefully diminish the chance of graft failure or GvHD Dispanties in the class II n.mon fl ° might be of particular interest because of theii role in activation of the immune response although at least in a related Situation, there is no consensus on ihc correlation between DP incompatibility and the oecurrence ot GvHD 64 
HJTURE INVESTIGATIONS AND THEORETICAL CONSIDERATIONS
Which Cells Cause GvHD to Minor Η Antigens?
In the mouse, a vanety of studies have been carned out to explore the identity tnd lunction of cells responsible for GvH leaction After the mitiating expenments I Boak and Wilson' 5 who showed that allogeneic lymphoid cell populations devoid I donor Τ cells do not indute GvH disease, and thosc of Koingold and Spient 1 " who showed that by removmg mature Τ cells from the marrow, lethal GvHD across minor Η barners could be prevented, the question of which donor Τ cells populations are involved in the induction of GvHD was largely surveyed Α prehminary report on the charactenzation of the cells involved in H-2 restncted GvH reactions showed that both the Lyt 1 + 2 and Lyt 1 2 f populations were involved 66 Recently, more precise Information became available showing that Lyt 2+ Τ cells as well as L3T4 + cells cause GvHD to minor Η antigen differences bl Moreover, the Τ cell subsets lnitiating the GvHD may differ for each strain combination, a mixture of the Lyt 2 f and L3T4 + Τ cell subsets, however, results in a severe form of GvHD 68 The complexity of the immunological reactions lnitiating GvHD due to minor Η antigen differences becomes even greater when we have to take into aecount Parkman's findings that possibly different cellular mechanisms act m acute versus chrome GvHD m Parkman charactenzed, by photypic and functional analysis at the clonal level, the cells involved in acute GvHD and found that they were different from the clones established dunng the chronic phase of the disease ω In man, much less IS known about the charactenstics of the cells responsible for lnitiating GvHD across non-MHC barners Dunng the last few years, several investigators aimed at unmasking at least some of the minor Η antigen specific cells playing a functional role in the course of the events after transplantation of bone marrow Irle and colleagues 70 studied the change, dunng in vitro cultunng, of specific cytolytic activity patterns in a senes of minor Η antigen specific clones obtamed from a marrow transplant patient after in vivo pnming Tilkin et al 71 desenbed a prohferative as well as cytotoxic mainly CD4 positive Τ cell hne, isolated after transplantation of bone marrow, recogmzing a minor Η antigen in the context of seif MHC class 11 The peeuhanty of the latter Τ cell hnc, which was of donor ongin, is that lt showed autoreactivity and consequently might be of importance in the reconstitution of the marrow and recovery of the immune svstem after transplantation As mentioned in earher sections, we recently gathered Information upon tht composition and the function of the minor Η antigen specific effector cells at different times after transplantation of bone marrow
Expression of Minor Η Antigens in the Skin
One of the affected organs dunng GvHD aftei bone marrow grafting is the skin 1 he assumplion that donor Τ cells are responsible for the epidermal lesions is generally aeeepted in mouse and man In the mouse, Piguet et al 72 investigated the epidermal lesions of GvHD ehcited by minor loci, whole MHC differences or a MHC class I or II dilference alone They showed that donor Τ lymphocytes L3T4 ' Ly2 as well as L3T4 I y 2' can ehcit the epidermal lesions in the vanous donor/recipient combinations Similarly, epidermal damage resultmg from a marrow exchange over a minoi Η antigen difference alone was reported earher n u These expenmental animal ddta lead to the search for the target stiucture(s) causing the damage of the epiderrms The antigens functionmg as Sites of attack could be for instance tissuc iestncted histocompatibihty antigens such as the epidermal alloantigen Bpa 1
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In subsequent studies, Steinmuller et al demonstrated that by immune lymphocyte iransfer tests ι e injection of anti Epa 1 CTL clones, GvH lesions developed in Η 2k, Epa 1 positive hosts 76 In man, Guyotat et al 77 carned out histological and immunopathological studies on senal skin biopsies from patients after bone marrow transplantation Dermal and epidermal Infiltration by CD8 + cells correlated with the seventy of GvHD The pnmary Sites of attack in early GvH in the skin are the rete ndge keratinocytes 78 The antigenic target structures involved could be tissue specific antigens (expressed on epithehal but not on lymphoid cells) hke in the studies of Tsoi et al 79 On the other hand, minor Η antigen specific prohferative responses were also descnbed Reinsmoen et al 80 took skin biopsies at the Site of the GvHD lesions, cultured them and observed secondary prohferative responses in the presence of the patient's pretransplant cells With regard to our own studies, we are presently explonng the txpression of the minor Η antigens HA 1 to HA 5 on keratinocytes with the HA spetific cytotoxic typing reagents Two most elegant approaches for detecting minor Η antigen differences pnor to transplant were repoited by Vogelsang et al 8I and Bdgot et al 82 using a skin explant model and a mixed epidermal cell lymphocyte ttaction respectively Both test Systems appeared to have predictive value, which obviously IS very useful for donor selection The minor Η antigens inducing the aetivities in the latter Systems remained, to my knowledge, umdentified
The Desired Side-effect of GvHD
We posed ourselves the question whether the posttransplant anti host CTL activity ihat runs through this chapter hke a continuous thread might also be of advantage lo ihe bone matrow tiansplant recipients 7 Do the patients benefit fiom anti host CTL )i_tivity' The hypothesis that posttransplantation of bone marrow anti host CTL lUivity may have a beneficial effect IS based on the aasurnption of the postulated mti leukaemic potential as a 'desired' side effect oi the post bone marrow transplant uimphcation GvH M 85 The current thoughts about GvL following bone marrow nansplantation has been recently summanzed by Buttunni et al 8i) In the third part of Fig 3-1 showing donor Γ cells lesponsible for GvL, only pi diminary results from our laboratory are availible The Information from the initial L\pcnments can be summanzed as follows fnst, some HA specific CTL seemed to κ n.t with leukaemic cells, second, the HA antigen expression, as tested by quantitative old target Inhibition expenments, can vary which might be depending on the Jiiluentiation State of the leukaemic cells As mentioned earher the host directed I LÜI populations generated in patients suffenng from acute GvHD (woik in progress) ind in patients without any chnical signs of GvHD are of course of pnme importance toi the determination of their role in the GvL reaction Regalding the tew in vitro inmiine studies in man to date on the mechamsms preventing leukaemia relapse after I um. marrow transplantation, one detailed chnical and laboratory study by Sondell >-t il deserves Special notice 87 These authors descnbed the lecurrence of the disease II ψιΐβ the engraftment of donor marrow and the (secondary) tapabihty of the donor IK to destroy the leukaemic cells Hopefully, such studies will facihtate the seaich ι n the exact balance between GvH and GvL, yielding a higher etficacy for chnical l'oni. marrow transplantation What are Minor Η Antigens* The answer to this question can be either very short or extremely long, becau nobody knows exactly Α vanety of proposals about the nature of the minor Η antige suggest that they may be quite different from one another and quite different fro the functions of the antigens of the MHC complex, 88 they are probably membrat bound and present on several tissues, lt IS unlikely that they are pnmanly concerm wtth transplantation per se, they may be a diverse group of molecules participatir in vanous cellular housekeeping functions and their antigenicity may come vei inudentally, perhaps as a resuit of their expression in the plasma membrane, 8 -1 ο minors are frankly mystenous entities, they fall to mduce an antibody response, the are naturally processed fragments of polymorphic nucleoproteins that associate wil MHC products % None of these utterances can yet be proved false As httle as vi know now from the studies on human minor Η antigens, U is clear from our dal that even the minor Η antigens which we detected by CTLs can be quite dilferei from one anolher This is supported by the observation that the HA 3 antigen determinant most probably differs from HA 1,2,4 and 5 in lts role in the developmei of GvHD and by lts expression on HPC In general, no antibody responses again minor Η antigens are observed except for HY" The absence of these antibodic falls in the same category as the 'MHC restncted plus X' antibodies Although th number of antigen specific MHC restncted antibodies reported does not reat overwhelming Icvels, the independent observations recently summan/ed, p strongl suppoit the notion that they exist One of the previous proposals on minor Η antigei furnishes food for reflection 'such mystenous entities' could well be proeessc antigenic peptides from viruses In the framework of the multifaetonal aetiology ο GvHD," lt is of interest to examine our HA specific cellular ieagents for possibl reactivity against virus infected target cells Finally, findings in the mouse by Colomb et al g4 add an extra dimension to the creative thoughts on the nature of minor l antigens These authors ieported on the expression of new non Η 2 histocompatibilil antigens (as defined by skm graft rejettion and by CTL sj through germ line msertio of d gtne from retroviral origin 
